Eco R1 Capital, LLC Relay Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

$2.14 Billion
Q4 2024

A detailed history of Eco R1 Capital, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 641,426 shares of RLAY stock, worth $2.51 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

641,426

Previous 2,500,000 74.34%

Holding current value

$2.51 Million

Previous $17.7 Million 85.07%

% of portfolio

0.12%

Previous 0.77%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.12 - $6.8 $7.66 Million - $12.6 Million	-1,858,574 Reduced 74.34%	641,426 $2.64 Million
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $15.6 Million - $23.8 Million	2,500,000 New	2,500,000 $17.7 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $7.96 Million - $13.8 Million	440,283 Added 11.82%	4,163,824 $93.1 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $19.1 Million - $50 Million	1,432,100 Added 62.5%	3,723,541 $62.4 Million
Q1 2022 May 16, 2022	BUY	$20.26 - $32.36 $10.4 Million - $16.6 Million	512,357 Added 28.8%	2,291,441 $68.6 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $10.2 Million - $14.6 Million	393,808 Added 28.43%	1,779,084 $54.6 Million
Q3 2021 Nov 15, 2021	SELL	$29.75 - $37.99 $92.3 Million - $118 Million	-3,102,500 Reduced 69.13%	1,385,276 $43.7 Million
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $29.1 Million - $40.4 Million	1,058,413 Added 30.86%	4,487,776 $164 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $7.44 Million - $14.1 Million	228,714 Added 7.15%	3,429,363 $119 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $105 Million - $144 Million	3,200,649 New	3,200,649 $136 Million

Others Institutions Holding RLAY

# of Institutions

207

Shares Held

159M

Call Options Held

100K

Put Options Held

26.8K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $471M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Account

Eco R1 Capital, LLC Relay Therapeutics, Inc. Transaction History